Phosphatidylinositol-3 phosphate kinase (PI3K) and phosphatase protein homologue to tensin (PTEN) are involved in cell signaling by catalyzing opposite reactions in the balance of phosphatidylinositol-3,4,5,-trisphosphate and are deregulated in many tumors. Recently, Saal et al. (1) reported that these two proteins are altered in a consistent fraction of breast cancers and, more importantly, that PIK3CA mutations and PTEN loss seem mutually exclusive. These results prompted us to verify a possible correlation between PI3K mutations and PTEN protein deregulation also in colorectal cancer, where both of them have been shown to play a relevant role (2, 3).
